Drug Trial Radar · NCT07218926
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Dec 3, 2025
Primary completion
May 30, 2028
Study completion Nov 29, 2030
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find out if a new drug, called IDRX-42 (also known as GSK6042981), is effective in treating adults with a type of cancer called Gastrointestinal Stromal Tumors (GIST) when compared to another drug named sunitinib. The study will see if IDRX-42 works well and is safe for participants whose GIST has spread or cannot be surgically removed, and who have already taken the drug imatinib. Participants whose disease worsens after receiving sunitinib in this study may cross over to receive GSK6042981, at investigator's discretion and if additional eligibility criteria are met.
Conditions
- Gastrointestinal Neoplasms
Interventions
IDRX-42Drug
IDRX-42 will be administered.
SunitinibDrug
Sunitinib will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS)Time frame: Up to approximately 130 weeks
Locations
156 sites in 19 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Phoenix, Arizona · Recruiting
GSK Investigational Site
Duarte, California · Recruiting
GSK Investigational Site
La Jolla, California · Recruiting
GSK Investigational Site
Los Angeles, California · Recruiting
GSK Investigational Site
San Francisco, California · Recruiting
GSK Investigational Site
Santa Monica, California · Recruiting
GSK Investigational Site
Upland, California · Recruiting
GSK Investigational Site
Aurora, Colorado · Recruiting
GSK Investigational Site
New Haven, Connecticut · Recruiting
GSK Investigational Site
Washington D.C., District of Columbia · Recruiting
GSK Investigational Site
Jacksonville, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Orlando, Florida · Recruiting
GSK Investigational Site
Tampa, Florida · Recruiting
GSK Investigational Site
Chicago, Illinois · Recruiting
GSK Investigational Site
Chicago, Illinois · Recruiting
GSK Investigational Site
Iowa City, Iowa · Recruiting
GSK Investigational Site
Overland Park, Kansas · Recruiting
GSK Investigational Site
Baton Rouge, Louisiana · Recruiting
GSK Investigational Site
Baltimore, Maryland · Recruiting
GSK Investigational Site
Boston, Massachusetts · Recruiting
GSK Investigational Site
Boston, Massachusetts · Recruiting
GSK Investigational Site
Ann Arbor, Michigan · Recruiting
GSK Investigational Site
Rochester, Minnesota · Recruiting
GSK Investigational Site
St Louis, Missouri · Recruiting
GSK Investigational Site
Omaha, Nebraska · Recruiting
GSK Investigational Site
New Hyde Park, New York · Recruiting
GSK Investigational Site
New York, New York · Recruiting
GSK Investigational Site
New York, New York · Recruiting
GSK Investigational Site
Rochester, New York · Recruiting
GSK Investigational Site
Charlotte, North Carolina · Recruiting
GSK Investigational Site
Durham, North Carolina · Recruiting
GSK Investigational Site
Canton, Ohio · Recruiting
GSK Investigational Site
Columbus, Ohio · Recruiting
GSK Investigational Site
Portland, Oregon · Recruiting
GSK Investigational Site
Philadelphia, Pennsylvania · Recruiting
GSK Investigational Site
Philadelphia, Pennsylvania · Recruiting
GSK Investigational Site
Pittsburgh, Pennsylvania · Recruiting
GSK Investigational Site
Spartanburg, South Carolina · Recruiting
GSK Investigational Site
Knoxville, Tennessee · Recruiting
Showing 40 of 156 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.